四合饮治疗乙型病毒性肝炎肝硬化腹水临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R657.3+1;R512.6+2

基金项目:


Clinical Study on Sihe Yin for Hepatitis B Complicated with Liver Cirrhosis Ascites
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察四合饮治疗乙型病毒性肝炎肝硬化腹水的临床疗效。方法:将81 例肝硬化腹水患者随机分为2 组。对照组采用西医常规综合治疗,治疗组在对照组治疗方案的基础上加用中药四合饮治疗。观察并比较2 组治疗前后症状、体征及肝功能、肝纤维化指标变化等情况。结果:临床疗效总有效率治疗组95.1%,对照组82.5%,2 组比较,差异有统计学意义(P<0.05)。治疗后,2 组谷丙转氨酶(ALT)、谷草转氨酶(AST)、白蛋白(Alb)、总胆红素(TBil) 均较治疗前改善,差异均有统计学意义(P<0.05);治疗组ALT、AST、Alb 分别与对照组比较,差异均有统计学意义(P<0.05)。治疗组透明质酸酶(HA)、Ⅲ型前胶原(PCⅢ)、Ⅳ型胶原(ⅣC)、层粘连蛋白(LN)、FibroScan 检测的肝脏硬度值(LSM) 均较治疗前改善,差异均有统计学意义(P<0.05);对照组治疗后仅HA、ⅣC、LSM 较治疗前改善,差异均有统计学意义(P<0.05);治疗组HA、PCⅢ、ⅣC、LN、LSM 的改善程度优于对照组,差异均有统计学意义(P<0.05)。2 组在治疗过程中均未出现明显不良反应。结论:四合饮能够有效缓解乙型病毒性肝炎肝硬化腹水患者的临床症状,对患者的肝功能、肝纤维化指标也有效改善,显示其具有减轻肝脏炎症损伤和肝纤维化的作用。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Sihe yin for hepatitis B complicated with liver cirrhosis ascites. Methods:A total of 81 cases of patients with hepatitis B complicated with liver cirrhosis ascites were randomly divided into two groups. The control group was given routine comprehensive treatment of western medicine,and the treatment group was additionally treated with Sihe yin based on the treatment scheme of the control group. Changes in symptoms,signs,the liver function,and indexes of liver fibrosis before and after treatment were observed and compared between the two groups. Results:The total clinical effective rate was 95.1% in the treatment group,and 82.5% in the control group,the difference being significant(P<0.05). After treatment, levels of alanine aminotransferase(ALT), aspartate aminotransferase(AST), albumin(ALB), and total bilirubin(TBil) in the two groups were improved when compared with those before treatment(P< 0.05),and the improvement of ALT,AST and Alb in the treatment group was better than that in the control group(P<0.05). Hyaluronidase(HA), type Ⅲ procollagen(PC Ⅲ), type Ⅳ collagen( Ⅳ C), laminin(LN), and liver stiffness measure(LSM) detected by FibroScan in the treatment group were improved when compared with those before treatment,differences being significant(P<0.05). After treatment,in the control group,only HA,Ⅳ C,and LSM were improved when compared with those before treatment,differences being significant(P<0.05). The improvement on HA,PC Ⅲ,Ⅳ C,LN,and LSM in the treatment group was better than that in the control group, differences being significant(P<0.05). There was no significant adverse reaction in the two groups during the treatment. Conclusion:Sihe yin can effectively relieve the clinical symptoms of patients with hepatitis B complicated with liver cirrhosis ascites,and improve the liver function and indexes of liver fibrosis, with the function of alleviating liver inflammation and fibrosis.

    参考文献
    相似文献
    引证文献
引用本文

宋爱军,胡经航.四合饮治疗乙型病毒性肝炎肝硬化腹水临床研究[J].新中医,2021,53(13):72-74

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-07-11
  • 出版日期:
文章二维码